Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO), ...

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...

Novo Nordisk shares fell Tuesday after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant's blockbuster shots. Shares fell as much as 9.8% in ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Novo Nordisk A/S (NVO) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks ...

BT: How does Novo Nordisk view competition in the obesity treatment space? VS: Obesity is a complex chronic disease affecting millions globally. Tackling it requires a collective effort — no ...

It has been a tough period for Novo Nordisk shareholders. In the summer of 2024 ... military attack,” he said at a press conference in Copenhagen.“There is no direct […] The EU will delay its response ...

For years, most countries, including the US, have imposed few or no tariffs on finished drugs ... Novartis, and Novo Nordisk - the maker of the star diabetes type 2 drug Ozempic - expressed ...

No­vo Nordisk fo­cused on a unique ar­gu­ment in fed­er­al ap­peals court on Tues­day in a case that will con­sid­er the ex­tent to which the ju­di­cia­ry … ...